Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 80255 BALTIMORE, MD
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,288,774
+$1,772,207 QoQ
Shares Held
155,066
+27.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 192 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. SLS ranks #148 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in SLS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,288,774 155,066
2026-03-31 $516,567 122,120
2025-12-31 $237,608 63,026
2025-09-30 $77,213 47,959
2025-06-30 $105,030 47,959
2023-03-31 $24,453 17,100
2022-12-31 $40,356 17,100
2022-09-30 $34,542 17,100
2022-06-30 $38,133 17,100
2022-03-31 $114,228 17,100
2021-12-31 $94,563 17,100
2021-09-30 $98,012 10,700
2021-06-30 $172,050 15,500
2021-03-31 $231,434 27,100